Clik here to view.
SNU Bundang Hospital and Cipherome, Inc. conclude an MOU for cooperation in...
SAN JOSE, Calif. Seoul National University (SNU) Bundang Hospital Biomedical Research Institute announced that it concluded the MOU on November 15, 2022, to standardize clinico genomic research...
View ArticleClik here to view.
BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib)...
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the European Commission (EC) has...
View ArticleClik here to view.
EdiGene Announces Completion of Last Patient Dosing in Phase I Clinical Trial...
BEIJING & WALTHAM, Mass. EdiGene, Inc., a global, clinical-stage company focused on translating gene-editing technologies into transformative genetic medicines for patients with significant...
View ArticleClik here to view.
OliX Pharmaceuticals Publishes Preclinical Research Demonstrating OLX104C’s...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced the publication of preclinical research on the androgenetic alopecia (hair...
View ArticleClik here to view.
GFlow Neural Networks To Help Accelerate Molecules And Candidates Generation,...
HANOI, Vietnam The demand to find new ways to combat disease is rising by the day. Humanity is always at risk of a new pandemic, and the mutation of viruses creates resistance to antibiotics....
View ArticleClik here to view.
Aurion Biotech Expands Its Leadership Team
SEATTLE, BOSTON & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has appointed Sherita Hall as...
View ArticleClik here to view.
レビタスバイオが経営幹部を強化
米カリフォルニア州メンロパーク （ビジネスワイヤ） — ライフサイエンス市場にエンドツーエンドの試料処理・細胞分析サービスを提供する一流企業のレビタスバイオは、レビタスバイオ・ヨーロッパの国際商務担当シニアバイスプレジデントにドミニク・レミ・ルヌーを採用し、取締役にグレッグ・ヘレマを任命したと発表しました。...
View ArticleClik here to view.
LevitasBio补强公司高级管理层
加州门洛帕克 (美国商业资讯)–生命科学领域市场领先的端到端样本处理和细胞分析技术提供商LevitasBio, Inc.宣布，聘请Dominique Remy-Renou担任LevitasBio Europe BV全球商业运营高级副总裁，同时任命Greg Herrema为公司董事会成员。...
View ArticleClik here to view.
Novo Nordisk ＆ ATLATL announce winners in their joint program EntreStar
BEIJING Novo Nordisk Research Centre China (NNRCC) and ATLATL jointly announce the winners of EntreStar program. Hangzhou DNano MetaBio and Modit Medicine stood out among all participants and won...
View ArticleClik here to view.
Kite and Daiichi Sankyo Announce Changes to YESCARTA® CAR T-Cell Therapy...
SANTA MONICA, Calif. & TOKYO Kite Pharma, Inc., a Gilead Company, (hereafter Kite) and Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo) today jointly announced the revision of their 2017...
View ArticleClik here to view.
Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing...
SAN DIEGO & DUBLIN Crown Bioscience, Inc, a JSR Life Sciences Company, and ERS Genomics Limited (‘ERS’) have signed a global license agreement for access to the foundational CRISPR/Cas9 patent...
View ArticleClik here to view.
Crown Bioscience と ERS Genomics がグローバルでゲノム編集に関わる CRISPR/Cas9 のライセンス契約を発表
米国サンディエゴおよびアイルランド・ダブリン （ビジネスワイヤ） — JSRライフサイエンスの Crown Bioscience と ERS Genomics 社（以下、ESR）は ESR が保有する CRISPR/Cas9 の関連特許利用に関わるグローバルライセンス契約を締結し、グローバルでのCRISPR/Cas9 を用いたゲノム編集に関わる完全なライセンスを受けることになりました。...
View ArticleClik here to view.
冠科生物宣布与ERS Genomics签订基因编辑专利CRISPR/Cas9的全球性许可协议
美国圣地亚哥和爱尔兰都柏林 (美國商業資訊)– 冠科生物（JSR生命科学集团旗下子公司）宣布与ERS Genomics Limited（简称“ERS”）签订了一份授权使用ERS的CRISPR/Cas9原始专利许可协议，这意味着冠科生物能够在全球全权使用CRISPR/Cas9进行基因编辑研究。 本新聞稿包含多媒體資訊。完整新聞稿請見此：...
View ArticleClik here to view.
REGiMMUNE Presented Positive Results of RGI-2001 in the Reduction of Acute...
TAIPEI, Taiwan REGiMMUNE Limited, a clinical-stage biopharmaceutical company developing innovative immunotherapies for immune disorders and cancer, today announced the positive results of their...
View ArticleClik here to view.
Yescarta® Now Approved in Japan for Initial Treatment of Relapsed/Refractory...
SANTA MONICA, Calif. & TOKYO Kite Pharma, Inc., a Gilead Company, (hereafter, Kite) (NASDAQ: GILD) and Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo) (TSE: 4568) today jointly announced...
View ArticleClik here to view.
BeiGene Announces Acceptance of 12th Regulatory Submission in China for PD-1...
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company announced that the Center for Drug Evaluation (CDE) of the...
View ArticleClik here to view.
CANbridge Consolidates Gene Therapy Portfolio
BEIJING & BURLINGTON, Mass. CANbridge Pharmaceuticals, Inc. (1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research, development and...
View ArticleClik here to view.
BeiGene to Present at the J.P. Morgan 41st Annual Healthcare Conference
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company today announced that the Company will participate in the J.P....
View ArticleClik here to view.
Twist Bioscience、アステラス製薬と複数標的抗体発見に関する共同研究契約を締結
カリフォルニア州サンフランシスコ （ビジネスワイヤ） — シリコンプラットフォームを用いた高品質な合成DNAの提供を通じて顧客の成功を支援するTwist Bioscience Corporation（NASDAQ: TWST、以下「Twist社」）は、アステラス製薬株式会社（TSE:...
View ArticleClik here to view.
Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery...
SOUTH SAN FRANCISCO, Calif. Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today...
View Article